Cargando…

Predictive Value of XPD Polymorphisms on Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

BACKGROUND: The correlation between xeroderma pigmentosum group D (XPD) polymorphisms (Lys751Gln and Asp312Asn) and clinical outcomes of non-small cell lung cancer (NSCLC) patients, who received platinum-based chemotherapy (Pt-chemotherapy), is still inconclusive. This meta-analysis was aimed to sys...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiu, Mantang, Yang, Xin, Hu, Jingwen, Ding, Xiangxiang, Jiang, Feng, Yin, Rong, Xu, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747109/ https://www.ncbi.nlm.nih.gov/pubmed/23977265 http://dx.doi.org/10.1371/journal.pone.0072251

Ejemplares similares

XRCC3 Thr241Met Is Associated with Response to Platinum-Based Chemotherapy but Not Survival in Advanced Non-Small Cell Lung Cancer
por: Qiu, Mantang, et al.
Publicado: (2013)

Effect of Polymorphisms in XPD on Clinical Outcomes of Platinum-Based Chemotherapy for Chinese Non-Small Cell Lung Cancer Patients
por: Wu, Wenting, et al.
Publicado: (2012)

Predictive Value of Ercc1 and Xpd Polymorphisms for Clinical Outcomes of Patients Receiving Neoadjuvant Therapy: A Prisma-Compliant Meta-Analysis
por: Qixing, Mao, et al.
Publicado: (2015)

Polymorphisms in XPD Gene Could Predict Clinical Outcome of Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer Patients: A Meta-Analysis of 24 Studies
por: Qin, Qin, et al.
Publicado: (2013)

Effect of XPD and TP53 Gene Polymorphisms on the Risk of Platinum-Based Chemotherapy Induced Toxicity in Bangladeshi Lung Cancer Patients
por: Nairuz, Tahsin, et al.
Publicado: (2021)

XPD gene polymorphism and colorectal cancer risk
por: Kashfi, Seyed Mohammad Hossein, et al.
Publicado: (2013)

Associations Between XPD Lys751Gln Polymorphism and Leukemia: A Meta-Analysis
por: Wen, Min, et al.
Publicado: (2018)

XRCC1 and XPD genetic polymorphisms and susceptibility to age-related cataract: A meta-analysis
por: Chi, Xin-Xin, et al.
Publicado: (2015)

The Effect of XPD Polymorphisms on Digestive Tract Cancers Risk: A Meta-Analysis
por: Du, Haina, et al.
Publicado: (2014)

XPD Polymorphisms and Risk of Hepatocellular Carcinoma and Gastric Cancer: A Meta-Analysis
por: Zhou, Qiang, et al.
Publicado: (2021)

Effect of XPC polymorphisms on the response to platinum-based chemotherapy: a meta-analysis
por: Xie, Chenyao, et al.
Publicado: (2019)

Influence of Methylenetetrahydrofolate Reductase C677T Polymorphism on the Risk of Lung Cancer and the Clinical Response to Platinum-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer: An Updated Meta-Analysis
por: Zhu, Ning, et al.
Publicado: (2013)

Polymorphisms in XPD and ERCC1 Associated with Colorectal Cancer Outcome
por: Huang, Ming-Yii, et al.
Publicado: (2013)

Crumbs and Xpd in mitosis
por: Yeom, Eunbyul, et al.
Publicado: (2015)

Genetic Polymorphisms and Platinum-based Chemotherapy Treatment Outcomes in Patients with Non-Small Cell Lung Cancer: A Genetic Epidemiology Study Based Meta-analysis
por: Tan, Li-Ming, et al.
Publicado: (2017)

On the traces of XPD: cell cycle matters - untangling the genotype-phenotype relationship of XPD mutations
por: Cameroni, Elisabetta, et al.
Publicado: (2010)

XPD–The Lynchpin of NER: Molecule, Gene, Polymorphisms, and Role in Colorectal Carcinogenesis
por: Sameer, Aga Syed, et al.
Publicado: (2018)

XRCC1 and XPD polymorphisms and their relation to the clinical course in hepatocarcinoma patients
por: Guan, Qinghai, et al.
Publicado: (2017)

Prognostic value of serum cytokeratin 19 fragments (Cyfra 21-1) in patients with non-small cell lung cancer
por: Xu, Youtao, et al.
Publicado: (2015)

Meta-Analysis on Pharmacogenetics of Platinum-Based Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Patients
por: Yin, Ji-Ye, et al.
Publicado: (2012)

A Significant Statistical Advancement on the Predictive Values of ERCC1 Polymorphisms for Clinical Outcomes of Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer: An Updated Meta-Analysis
por: Han, Yali, et al.
Publicado: (2016)

XPD gene polymorphism and host characteristics in the association with cutaneous malignant melanoma risk
por: Baccarelli, A, et al.
Publicado: (2004)

Pterygium and genetic polymorphisms of the DNA repair enzymes XRCC1, XPA, and XPD
por: Chiang, Chun-Chi, et al.
Publicado: (2010)

XPD Asp312Asn and Lys751Gln polymorphisms and breast cancer susceptibility: A meta-analysis
por: Yan, Yulan, et al.
Publicado: (2013)

Lack of association between the XPD Lys751Gln polymorphism and colorectal cancer risk: a meta-analysis
por: Zhang, Tao, et al.
Publicado: (2014)

WISP1 Polymorphisms Contribute to Platinum-Based Chemotherapy Toxicity in Lung Cancer Patients
por: Chen, Juan, et al.
Publicado: (2014)

XPD Polymorphisms and Risk of Squamous Cell Carcinoma of the Head and Neck in a Korean Sample
por: Ji, Yong Bae, et al.
Publicado: (2010)

XPD codon 312 and 751 polymorphisms, and AFB1 exposure, and hepatocellular carcinoma risk
por: Long, Xi Dai, et al.
Publicado: (2009)

Polymorphism of XRCC1, XRCC3, and XPD Genes and Risk of Chronic Myeloid Leukemia
por: Bănescu, Claudia, et al.
Publicado: (2014)

Association between DNA mismatch repair gene polymorphisms and platinum-based chemotherapy toxicity in non-small cell lung cancer patients
por: Liu, Jun-Yan, et al.
Publicado: (2017)

The prognostic value of the serum neuron specific enolase and lactate dehydrogenase in small cell lung cancer patients receiving first-line platinum-based chemotherapy
por: Liu, Xiaofan, et al.
Publicado: (2017)

Relevance of XPD polymorphisms to neuroblastoma risk in Chinese children: a four-center case-control study
por: Cheng, Jiwen, et al.
Publicado: (2018)

DNA translocation mechanism of an XPD family helicase
por: Cheng, Kaiying, et al.
Publicado: (2018)

The Effect of XPD/ERCC2 Polymorphisms on Gastric Cancer Risk among Different Ethnicities: A Systematic Review and Meta-Analysis
por: Xue, Huiping, et al.
Publicado: (2012)

TP53 Arg72Pro and XPD Lys751Gln Gene Polymorphisms and Risk of Lung Cancer in Bangladeshi Patients
por: Nairuz, Tahsin, et al.
Publicado: (2020)

Predictive value of EGFR mutation in non–small‐cell lung cancer patients treated with platinum doublet postoperative chemotherapy
por: Takahashi, Toshiaki, et al.
Publicado: (2021)

Polymorphisms in two DNA repair genes (XPD and XRCC1) – association with age related cataracts
por: Padma, G., et al.
Publicado: (2011)

Polymorphisms of DNA repair genes OGG1 and XPD and the risk of age-related cataract in Egyptians
por: Gharib, Amal F., et al.
Publicado: (2014)

Genetic Polymorphisms and Platinum-Based Chemotherapy-Induced Toxicities in Patients With Lung Cancer: A Systematic Review and Meta-Analysis
por: Liu, Wenhui, et al.
Publicado: (2020)

The Effects of WISP1 Polymorphisms on the Prognosis of Lung Cancer Patients with Platinum-Based Chemotherapy
por: He, Jia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_depdd4jtdqgpr15dr9f7bule4u